(19)
(11) EP 1 228 221 A2

(12)

(88) Date of publication A3:
28.02.2002

(43) Date of publication:
07.08.2002 Bulletin 2002/32

(21) Application number: 00971299.3

(22) Date of filing: 27.10.2000
(51) International Patent Classification (IPC)7C12N 15/54, C12N 15/11, C12N 9/12, C07K 16/40, C12P 21/02, C12Q 1/68, A01K 67/027, G01N 33/68
(86) International application number:
PCT/EP0009/498
(87) International publication number:
WO 0131/029 (03.05.2001 Gazette 2001/18)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 28.10.1999 US 162307 P
07.02.2000 US 180525 P

(71) Applicant: WARNER-LAMBERT COMPANY
Morris PlainsNew Jersey 07950 (US)

(72) Inventors:
  • ALLEN, Janet
    Southall, Middlesex UB2 4LS (GB)
  • GOSINK, Mark
    Bothell, WA 98011 (US)
  • MELENDEZ, Alirio, J.
    Singapore 104001 (SG)
  • TAKACS, Laszlo
    F-92340 Bourg-la-Reine (FR)

(74) Representative: Dufresne, Guillaume Alain François et al
Pfizer Global Research & DevelopmentFresnes Laboratories3-9, rue de la LogeB.P. 100
94265 Fresnes Cédex
94265 Fresnes Cédex (FR)

   


(54) HUMAN SPHINGOSINE KINASE GENE